Amgen | AMGN - Le Chiffre D'Affaires De Vente

Prix De L'Action
338.62
Variation Quotidienne
-0.95 -0.28%
Mensuellement
-2.97%
Annuel
16.40%
Q2 Prévisions
337.18




Ventes Changement Date
AbbVie USD 15B 1.62B 2026-03
Agios Pharmaceuticals USD 18.8M 1.17M 2026-03
ALKERMES USD 384.5M 9.7M 2025-12
Amgen USD 9.9B 340M 2025-12
Biogen USD 2.25B 30M 2026-03
BioMarin Pharmaceutical USD 875M 99M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Coherus Biosciences USD 12.75M 1.18M 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Exelixis USD 598.66M 860K 2025-12
Genmab DKK 1.06B 36M 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 7.63B 991M 2026-03
Glaxosmithkline GBP 10.09B 1.37B 2026-03
Incyte USD 1.27B 240M 2026-03
Ionis Pharmaceuticals USD 246M 43M 2026-03
J&J USD 24.1B 500M 2026-03
Merck USD 16.4B 880M 2025-12
Moderna USD 678M 342M 2025-12
Neurocrine Biosciences USD 805.5M 10.6M 2025-12
Novartis USD 13.11B 226M 2026-03
Novartis USD 13.11B 750M 2026-03
Pfizer USD 17.58B 880M 2025-12
PTC Therapeutics USD 164.7M 46.3M 2025-12
Puma Biotechnology USD 80.54M 33.46M 2024-09
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.24B 60M 2026-03
Sarepta Therapeutics USD 442.9M 43.5M 2025-12
Takeda JPY 1.19T 80B 2025-12
Teva Pharmaceutical Industries USD 11.77B 2.86B 2026-03
Ultragenyx Pharmaceutical USD 207M 47M 2025-12
Vertex Pharmaceuticals USD 3.19B 110M 2025-12